CRISPR Therapeutics AG (CRSP)
40.53
+0.16
(+0.40%)
USD |
NASDAQ |
Nov 17, 13:42
CRISPR Therapeutics Total Return Level : 40.37 for Nov. 16, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 16, 2026 | 40.37 |
| November 13, 2026 | 42.24 |
| November 12, 2026 | 42.62 |
| November 11, 2026 | 45.75 |
| November 10, 2026 | 45.15 |
| November 09, 2026 | 50.04 |
| November 06, 2026 | 50.07 |
| November 05, 2026 | 48.56 |
| November 04, 2026 | 51.78 |
| November 03, 2026 | 49.99 |
| November 02, 2026 | 49.99 |
| October 30, 2026 | 51.42 |
| October 29, 2026 | 54.26 |
| October 28, 2026 | 54.11 |
| October 27, 2026 | 51.47 |
| October 26, 2026 | 49.01 |
| October 23, 2026 | 49.39 |
| October 22, 2026 | 49.99 |
| October 21, 2026 | 50.50 |
| October 20, 2026 | 49.88 |
| October 19, 2026 | 50.04 |
| October 16, 2026 | 49.25 |
| October 15, 2026 | 51.52 |
| October 14, 2026 | 50.22 |
| October 13, 2026 | 50.10 |
| Date | Value |
|---|---|
| October 12, 2026 | 51.55 |
| October 09, 2026 | 53.39 |
| October 08, 2026 | 50.44 |
| October 07, 2026 | 52.35 |
| October 06, 2026 | 54.00 |
| October 05, 2026 | 57.34 |
| October 02, 2026 | 55.43 |
| October 01, 2026 | 55.44 |
| September 30, 2026 | 55.32 |
| September 29, 2026 | 56.00 |
| September 28, 2026 | 54.09 |
| September 25, 2026 | 54.23 |
| September 24, 2026 | 55.70 |
| September 23, 2026 | 55.76 |
| September 22, 2026 | 59.03 |
| September 21, 2026 | 58.33 |
| September 18, 2026 | 56.56 |
| September 17, 2026 | 57.32 |
| September 16, 2026 | 52.21 |
| September 15, 2026 | 51.83 |
| September 14, 2026 | 52.96 |
| September 11, 2026 | 51.72 |
| September 10, 2026 | 52.26 |
| September 09, 2026 | 53.45 |
| September 08, 2026 | 54.78 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Vertex Pharmaceuticals, Inc. | 537.79 |
| Basilea Pharmaceutica AG | 84.00 |
| Santhera Pharmaceuticals Holding AG | 18.30 |
| BeOne Medicines Ltd. | 411.29 |
| Intellia Therapeutics, Inc. | 9.86 |